GB Sciences, Inc.
GBLX · OTC
12/31/2024 | 9/30/2024 | 6/30/2024 | 3/31/2024 | |
|---|---|---|---|---|
| Market Cap | $2 | $2 | $3 | $3 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $2 | $2 | $2 | $2 |
| Enterprise Value | $4 | $4 | $5 | $4 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 100% | – | – | – |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -68.3% | – | – | – |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -103.2% | – | – | – |
| EPS Diluted | -0 | -0.001 | -0.001 | -0.001 |
| % Growth | 60% | 28.6% | 41.7% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$0 | $0 | -$0 | -$0 |